Planta Med 2004; 70(6): 569-571
DOI: 10.1055/s-2004-827161
Letter
© Georg Thieme Verlag KG Stuttgart · New York

Investigation of the Antifungal Activity of Caledonixanthone E and Other Xanthones Against Aspergillus fumigatus

Gérald Larcher1 , Cécile Morel2 , Guy Tronchin1 , Anne Landreau2 , Denis Séraphin2 , Pascal Richomme2 , Jean-Philippe Bouchara1
  • 1Groupe d'Etude des Interactions Hôte-Parasite, UPRES-EA 3142, Laboratoire de Parasitologie-Mycologie, Centre Hospitalier Universitaire, Angers, France
  • 2SONAS, UPRES EA 921, UFR des Sciences Pharmaceutiques et d'Ingénierie de la Santé, Angers, France
Further Information

Publication History

Received: November 27, 2003

Accepted: February 22, 2004

Publication Date:
01 July 2004 (online)

Abstract

Among the different xanthones previously isolated from the stem bark of Calophyllum caledonicum, caledonixanthone E presented the strongest activity (MIC80 = 8 μg/mL) in acidic conditions (pH 3) against the human pathogenic fungus Aspergillus fumigatus. Phase-contrast microscopy studies suggested the assembly or synthesis of cell wall components as the target of the drug. Moreover, the use of fluorescent lectins further supported an impact of caledonixanthone E on the synthesis of chitin, the major structural polysaccharide of the fungal wall. These results suggest that caledonixanthone E may be an interesting model for the design of new antifungal drugs.

References

  • 1 Morel C, Séraphin D, Teyrouz A, Larcher G, Bouchara J P, Litaudon M, Richomme P, Bruneton J. New and antifungal xanthones from Calophyllum caledonicum .  Planta Med. 2002;  68 41-4
  • 2 Morel C, Séraphin D, Oger J M, Litaudon M, Sévenet T, Richomme P, Bruneton J. New xanthones from Calophyllum caledonicum .  J Nat Prod. 2000;  63 1471-4
  • 3 National Committee for Clinical Laboratory S tandards. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved Standard M27-A. National Committee for Clinical Laboratory Standards Villanova, Pa; 1997
  • 4 Buchta V, Otcenasek M. Factors affecting the results of a broth microdilution antifungal susceptibility testing in vitro .  Zbl Bakt. 1996;  283 375-90
  • 5 Yamada H, Tsuda T, Watanabe T, Ohashi M, Murakami K, Mochizuki H. In vitro and in vivo antifungal activities of D0870, a new triazole agent.  Antimicrob Agents Chemother. 1993;  37 2412-7
  • 6 Lee S H, Lee J R, Lunde C S, Kubo I. In vitro antifungal susceptibilities of Candida albicans and other fungal pathogens to polygodial, a sesquiterpene dialdehyde.  Planta Med. 1999;  65 204-8
  • 7 Kurtz M B, Heath I B, Marrinan J, Dreikorn S, Onishi J, Douglas C. Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-D-glucan synthase.  Antimicrob Agents Chemother. 1994;  38 1480-9

Dr. Gérald Larcher

GEIHP

UPRES-EA 3142

Laboratoire de Parasitologie-Mycologie

Centre Hospitalier Universitaire

4 rue Larrey

49033 Angers

France

Phone: +33-02-41-35-34-72

Fax: +33-02-41-35-36-16

Email: gerald.larcher@univ-angers.fr

    >